Načítá se...
Is screening for interferon retinopathy in hepatitis C justified?
Background/aim: In the treatment of hepatitis C, the National Institute for Clinical Excellence advocates use of a combination of interferon alfa and ribavirin for selected patients. Retinopathy is a well recognised side effect of interferon therapy and is characterised by retinal haemorrhages, cott...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Copyright 2004 British Journal of Ophthalmology
2004
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1772411/ https://ncbi.nlm.nih.gov/pubmed/15548803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2004.043968 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|